Anna Koroleva
Impact in
-
- Diabetes Treatment and Management
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 8
-
- Metabolism, Diabetes, and Cancer 5
- Co-authors
- Signe Olrik Rytter Wallenstein (6 shared papers)Ildiko Lingvay (5 shared papers)Thomas A. Wadden (6 shared papers)W. Timothy Garvey (4 shared papers)Dorthe Skovgaard (1 shared paper)Juan P. Frías (2 shared papers)Patrick M. O’Neil (2 shared papers)Domenica Rubino (2 shared papers)
- Journals
- Diabetes (1 paper)Osteoarthritis and Cartilage (1 paper)JAMA (1 paper)New England Journal of Medicine (1 paper)The Lancet Diabetes & Endocrinology (1 paper)
- Partner nations
- United StatesDenmarkIreland
In The Last Decade
Anna Koroleva
11 papers receiving 958 citations
Anna Koroleva's Hit Papers
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 579
- Pharmacology 316
- Physiology 191
- Pharmacy 29
- Endocrine and Autonomic Systems 30
Countries citing papers authored by Anna Koroleva
This map shows the geographic impact of Anna Koroleva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Koroleva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Koroleva more than expected).
Fields of papers citing papers by Anna Koroleva
This network shows the impact of papers produced by Anna Koroleva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Koroleva. The network helps show where Anna Koroleva may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Koroleva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity Hit paper breakdown → | 2021 | 706 |
| 2 | Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis Hit paper breakdown → | 2024 | 163 |
| 3 | Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial Hit paper breakdown → | 2024 | 69 |
| 4 | 2024 | 16 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2022 | 0 |
About Anna Koroleva
Anna Koroleva is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Pharmacology, Surgery and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 980 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (5 papers), Pharmacology and Obesity Treatment (4 papers), Bariatric Surgery and Outcomes (1 paper), Inflammatory mediators and NSAID effects (1 paper), Asthma and respiratory diseases (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (579 citations), Pharmacology (316 citations), Physiology (191 citations), Pharmacy (29 citations) and Endocrine and Autonomic Systems (30 citations). Anna Koroleva has collaborated with scholars based in United States, Denmark and Ireland. Frequent co-authors include Signe Olrik Rytter Wallenstein, Ildiko Lingvay, Thomas A. Wadden, W. Timothy Garvey, Dorthe Skovgaard, Juan P. Frías, Patrick M. O’Neil, Domenica Rubino, Melanie J. Davies and Timothy S. Bailey. Their work appears in journals such as Diabetes, Osteoarthritis and Cartilage, JAMA, New England Journal of Medicine and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.